Zuzanna Musialska

Zuzanna Musialska

Auto-generated profile, based on publicly available information

Zuzanna Musialska

University Clinical Centre in Gdańsk, Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MSMarzena Swojnóg
Marzena Swojnóg
KPKinga Popielarska
Kinga Popielarska
MOMarta Opalińska-Kubowicz
Marta Opalińska-Kubowicz
ZMZuzanna Musialska
Zuzanna Musialska
YPYuliia Protsenko
Yuliia Protsenko
AMAdam Mazurek
Adam Mazurek
The dawn phenomenon (DP), defined as an early-morning rise in glucose unrelated to preceding nocturnal hypoglycemia, represents a significant yet often underrecognized contributor to fasting hyperglycemia and overall glycemic instability in individuals with diabetes. The expansion of continuous glucose monitoring (CGM) technologies over the past decade has enabled more precise characterization of nocturnal glucose patterns, offering new insights into the prevalence, magnitude, and clinical implications of DP across diverse glycemic states. This review synthesizes original observational, retrospective, and prospective studies published between 2010 and 2025 that used CGM to evaluate DP in type 1 diabetes, type 2 diabetes, impaired glucose tolerance, and non-diabetic populations. Data extraction focused on DP definitions, nocturnal glucose trajectories, glycemic variability metrics, associations with HbA1c and time-in-range, and emerging evidence linking severe DP to adverse clinical outcomes. Findings indicate that DP is highly prevalent in both type 1 and type 2 diabetes, with magnitude varying widely depending on residual β-cell function, insulin sensitivity, and methodological differences in CGM-based definitions. DP correlates with increased total glucose exposure and greater glycemic variability, and may influence long-term metabolic risk. Understanding DP within the context of CGM-derived metrics is essential for optimizing individualized therapeutic strategies and improving morning glycemic control. Further standardized research is required to unify definitions and clarify the prognostic significance of DP.

27 January 2026 in Quality in Sport
Verified
Journal Article
Open access
YPYuliia Protsenko
Yuliia Protsenko
MBMagdalena Barczewska
Magdalena Barczewska
AMAnna Marczak
Anna Marczak
MKMarta Kowalska
Marta Kowalska
DBDominika Bieszczad
Dominika Bieszczad
JAJulia Andrzejewska
Julia Andrzejewska
Background. Non-suicidal self-injury (NSSI) occurs in 69-90% of women with borderline personality disorder (BPD) and represents a critical diagnostic criterion and therapeutic challenge. Despite its high prevalence and clinical significance, the dynamic psychological and neurobiological mechanisms underlying NSSI remain incompletely understood, and a substantial gap persists between acute symptom reduction and long-term psychosocial recovery. Aim. This study reviews NSSI in BPD, focusing on: identification of proximal psychological mechanisms and developmental factors influencing NSSI risk, and assessment of specialized therapeutic approaches' effectiveness in reducing NSSI and achieving sustained psychosocial functioning. Materials and Methods. A literature review was conducted using databases (PubMed, PsycINFO, and Google Scholar) for articles up to November 2025. Inclusion criteria focused on peer-reviewed studies examining NSSI in BPD populations using validated assessment tools. Results. Neuroimaging demonstrates that NSSI produces immediate amygdala deactivation, providing neurobiological reinforcement for this behavior. The Emotional Cascade Model identifies rumination instability and emotion differentiation deficits as key triggers for NSSI episodes. Childhood trauma dysregulates the HPA axis and correlates with functional deficits. Dialectical Behavior Therapy (DBT) shows a moderate effect size in reducing self-harm (Hedges' g = -0.622) and induces neuroplastic changes. Mentalization-Based Therapy (MBT) reduces suicide attempts, though social functioning often remains impaired even in long-term follow-up. Conclusions. Specialized psychotherapies effectively stabilize acute symptoms, but a clear gap persists between symptom control and functional recovery. Future research should adopt complex dynamic systems perspectives and prioritize outcomes reflecting social integration and quality of life.

10 January 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
DBDominika Bieszczad
Dominika Bieszczad
MBMagdalena Barczewska
Magdalena Barczewska
AMAdam Mazurek
Adam Mazurek
KPKinga Popielarska
Kinga Popielarska
MOMarta Opalińska-Kubowicz
Marta Opalińska-Kubowicz
MSMarzena Swójnóg
Marzena Swójnóg
Background. Paediatric arterial ischemic stroke is a potentially disabling neurological condition that remains underrecognized due to its rarity and atypical clinical presentation. Diagnosis in children is often delayed because of heterogeneous symptoms and differences in stroke mechanisms compared with adults. Despite advances in neuroimaging and acute reperfusion therapies, evidence-based paediatric-specific diagnostic and treatment strategies remain limited. Aim. This review aimed to summarise current evidence regarding the epidemiology, pathophysiology, diagnostic approach, and management of acute ischemic stroke in the paediatric population. Material and methods. A narrative review of the literature was conducted using structured searches of PubMed, Google Scholar, and clinical guideline repositories. Articles published between 2015 and 2025 were included, comprising original studies, systematic reviews, meta-analyses, and international clinical guidelines focusing on risk factors, clinical presentation, neuroimaging, acute treatment, and secondary prevention. Results. Paediatric stroke differs substantially from adult stroke in etiology, clinical features, and outcomes. The most common causes include cerebral arteriopathies, congenital heart disease, infections, and haematological disorders such as sickle cell disease. Magnetic resonance imaging is the diagnostic modality of choice, with diffusion-weighted imaging and vessel wall imaging improving diagnostic accuracy. Intravenous thrombolysis and mechanical thrombectomy may be feasible and relatively safe in selected paediatric patients; however, high-quality evidence remains limited. Conclusion. Paediatric ischemic stroke remains a diagnostic and therapeutic challenge. Delayed recognition and heterogeneous mechanisms continue to limit optimal management. Further studies are needed to develop evidence-based paediatric guidelines and improve acute and long-term outcomes.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MKMarta Kowalska
Marta Kowalska
KPKinga Popielarska
Kinga Popielarska
MOMarta Opalińska-Kubowicz
Marta Opalińska-Kubowicz
ZMZuzanna Musialska
Zuzanna Musialska
YPYuliia Protsenko
Yuliia Protsenko
OBOliwia Barańska
Oliwia Barańska
Introduction and purpose: Anthracyclines are highly effective chemotherapeutic agents but carry a significant risk of dose-dependent cardiac toxicity, often progressing silently before left-ventricular ejection fraction (LVEF) declines. The objective of this review was to evaluate the role of three-dimensional echocardiography (3D-ECHO) and global longitudinal strain (GLS) in the early detection of subclinical anthracycline-induced cardiotoxicity and to compare their diagnostic performance with conventional 2D-LVEF assessment. Methods: A narrative review was conducted using clinical and observational studies indexed in PubMed over the last ten years. Only peer-reviewed human research evaluating anthracycline-induced cardiotoxicity was included. Studies comparing 2D-LVEF with 3D-LVEF and/or global longitudinal strain (GLS), as well as those assessing early markers of subclinical left-ventricular dysfunction, were selected. Extracted data focused on diagnostic effectiveness, time-to-detection of myocardial injury, and prognostic relevance of strain-based parameters. Conclusion: GLS and 3D-echocardiography outperform conventional 2D-LVEF in identifying early, subclinical anthracycline-related cardiotoxicity. GLS provides the highest sensitivity for early myocardial injury, while 3D-STE enhances spatial assessment and detects dysfunction before EF decline. Routine integration of these modalities into cardio-oncology surveillance may enable earlier intervention, prevent irreversible damage, and improve long-term cardiac outcomes.

2 January 2026 in Quality in Sport
Verified
Journal Article
Open access
MOMarta Opalińska-Kubowicz
Marta Opalińska-Kubowicz
KPKinga Popieralska
Kinga Popieralska
ZMZuzanna Musialska
Zuzanna Musialska
YPYuliia Protsenko
Yuliia Protsenko
MKMarta Kowalska
Marta Kowalska
AMAdam Mazurek
Adam Mazurek
Background. Obesity is becoming an increasingly serious problem in society and affects an entire human body including skin. It potentially affects barrier integrity, immune responses and susceptibility to dermatoses. Aim. This review aims to examine how obesity changes the composition and function of the skin microbiome and what are the possible consequences. Material and methods. A research was performed in the PubMed and Google Scholar based on peer-reviewed studies published between 2017 – 2025 and focusing on phrases “skin microbiome”, “obesity”, and “skin diseases”. Results. Available studies indicate reduced microbial diversity, increased colonisation by opportunistic pathogens and overgrowth of yeasts on the skin of obese patients. Mechanical factors such as friction, sweating and elevated skin-fold temperature promote dysbiosis and inflammation. These changes are associated with dermatoses such as atopic dermatitis, intertrigo, folliculitis, seborrhoeic dermatitis and hidradenitis suppurativa. Treatment strategies include weight reduction, targeted skincare, antimicrobial treatment and new microbiome-modulating therapies. Conclusions. Obesity significantly influences the skin microbiome, contributing to a higher risk of infections and inflammatory dermatoses. Although the understanding of these mechanisms is improving, further research, particularly involving metagenomics and metabolomics is needed to develop more precise preventive and therapeutic approaches.

2 January 2026 in Quality in Sport
Verified
Journal Article
Open access
MOMarta Opalińska-Kubowicz
Marta Opalińska-Kubowicz
KPKinga Popieralska
Kinga Popieralska
ZMZuzanna Musialska
Zuzanna Musialska
YPYuliia Protsenko
Yuliia Protsenko
MKMarta Kowalska
Marta Kowalska
AMAdam Mazurek
Adam Mazurek
Background. Obesity is becoming an increasingly serious problem in society and affects an entire human body including skin. It potentially affects barrier integrity, immune responses and susceptibility to dermatoses. Aim. This review aims to examine how obesity changes the composition and function of the skin microbiome and what are the possible consequences. Material and methods. A research was performed in the PubMed and Google Scholar based on peer-reviewed studies published between 2017 – 2025 and focusing on phrases “skin microbiome”, “obesity”, and “skin diseases”. Results. Available studies indicate reduced microbial diversity, increased colonisation by opportunistic pathogens and overgrowth of yeasts on the skin of obese patients. Mechanical factors such as friction, sweating and elevated skin-fold temperature promote dysbiosis and inflammation. These changes are associated with dermatoses such as atopic dermatitis, intertrigo, folliculitis, seborrhoeic dermatitis and hidradenitis suppurativa. Treatment strategies include weight reduction, targeted skincare, antimicrobial treatment and new microbiome-modulating therapies. Conclusions. Obesity significantly influences the skin microbiome, contributing to a higher risk of infections and inflammatory dermatoses. Although the understanding of these mechanisms is improving, further research, particularly involving metagenomics and metabolomics is needed to develop more precise preventive and therapeutic approaches.